NIH-funded research Career grant

Creating new bacterial viruses to fight antibiotic resistance

Official title: AN ADAPTIVE FRAMEWORK TO SYNTHESIZE AND RECONFIGURE BACTERIAL VIRUSES (PHAGES) TO COUNTER ANTIBIOTIC RESISTANCE

Funded at California Institute of Technology · NIH-11033792 · Data updated 2026-11-12

This study is exploring a new way to create and adjust viruses that can target and kill antibiotic-resistant bacteria, which could offer patients a helpful alternative to traditional antibiotics for treating tough infections.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionCalifornia Institute of Technology
NIH-funded
Lab location1 site (Pasadena, United States)
Project startDecember 1, 2024
Project endNovember 30, 2025
Funding year2025
Award (this year)$128,461
NIH project number1K99EB036553-01
Project IDNIH-11033792 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from infections caused by antibiotic-resistant bacteria.

Less likely to help

Patients with infections that are not caused by antibiotic-resistant bacteria may not benefit from this research.

What this research studies

This research focuses on developing a new method to create and modify bacterial viruses, known as phages, to effectively treat infections caused by antibiotic-resistant bacteria. The approach involves decompressing phage genomes to allow for more flexible engineering and rapid synthesis of these viruses using a cell-free system. By doing so, the researchers aim to enhance the scalability and accessibility of phage therapy, making it a viable treatment option for various drug-resistant infections. Patients may benefit from this innovative therapy as it could provide effective alternatives to traditional antibiotics.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for infections that are currently difficult to manage due to antibiotic resistance.

How similar studies have gone: Other research has shown promise in using phage therapy for antibiotic-resistant infections, indicating that this approach has potential for success.

Where this research is happening

  • California Institute of Technology
    Pasadena, United States
    Active

Researchers

  • Principal investigator: Zhang, Yan — California Institute of Technology
  • Study coordinator: Zhang, Yan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.